A Phase IIb Dose-Ranging Study of the Oral JAK Inhibitor Tofacitinib (CP-690,550) Versus Placebo in Combination With Background Methotrexate in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone

dc.contributor.author	Gómez-Reino Carnota, Juan Jesús
dc.date.accessioned	2017-06-07T07:17:04Z
dc.date.available	2017-06-07T07:17:04Z
dc.date.issued	2012
dc.identifier.issn	0004-3591
dc.identifier.uri	http://hdl.handle.net/20.500.11940/4707
dc.language.iso	eng
dc.title	A Phase IIb Dose-Ranging Study of the Oral JAK Inhibitor Tofacitinib (CP-690,550) Versus Placebo in Combination With Background Methotrexate in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone
dc.type	Artigo	es
dc.authorsophos	Kremer, J M
dc.authorsophos	Cohen, S
dc.authorsophos	Wilkinson, B E
dc.authorsophos	Connell, C A
dc.authorsophos	French, J L
dc.authorsophos	Gomez-Reino, J
dc.authorsophos	Gruben, D
dc.authorsophos	Kanik, K S
dc.authorsophos	Krishnaswami, S
dc.authorsophos	Pascual-Ramos, V
dc.authorsophos	Wallenstein, G
dc.authorsophos	Zwillich, S H
dc.identifier.doi	10.1002/art.33419
dc.identifier.isi	302475500006
dc.identifier.pmid	22006202
dc.identifier.sophos	7853
dc.issue.number	4
dc.journal.title	ARTHRITIS AND RHEUMATISM
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Reumatoloxía
dc.page.initial	970
dc.page.final	981
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	64

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.